SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-13
👔
TAKEDA PHARMACEUTICAL CO LTD
@TAK_InsiderForm 4 Filing: Plump Andrew Stewart Sells $2.8M of $TAK
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
TAKEDA PHARMACEUTICAL CO LTD
Ticker: $TAK
Transaction Value
$2.8M
Price/Share: $17.10
transaction date
2026-08-10
Shares: 165,393
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Plump Andrew Stewart, holds the title of President, R&D at TAKEDA PHARMACEUTICAL CO LTD.
On 2026-08-10, the insider transacted 165,393 shares.The shares were transacted at a weighted average price of $17.10 per share, resulting in a total market-relevant value of $2.8M.
Executive Summary Summary
Plump Andrew Stewart (President, R&D) sold $2.8M of $TAK
Post-Transaction Position: 766,569 shares
SEC Accession No: 0001493152-26-037507 (CIK: 1977689)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.